Researchers developed a 13-item liver-specific sexual function assessment tool that accurately identifies sexual dysfunction in patients with liver disease or post-LT.

Hydronidone significantly promotes liver fibrosis regression among patients with chronic hepatitis B (CHB), according to study results presented at the American Association for the Study of Liver ...

Phosphatidylethanol provides a strong diagnostic accuracy for detecting AUD among patients at risk for SLD, outperforming traditional biomarkers.

Semaglutide use among individuals with MASLD and type 2 diabetes is linked to lower risk for cirrhosis, fewer cirrhosis-related complications, and improved survival.

Mortality associated with chronic liver disease (CLD) and metabolic syndrome (MetS) increased substantially from 1999 to 2023 ...

Patients with lean vs nonlean metabolic dysfunction-associated steatotic liver disease (MASLD) have a significantly increased ...

A quality improvement initiative in a hepatology clinic increased alcohol use disorder pharmacotherapy prescriptions from 10% ...

Patients with different subtypes of metabolic syndrome experience varying prevalence rates of stroke and ischemic heart disease.

The Food and Drug Administration (FDA) has moved to restrict the sale of unapproved ingestible fluoride prescription drug products, stating that action will be taken against any company marketing the ...

Dr George Tidmarsh, the head of the FDA's drug division, stepped down Sunday after questioning a new fast-track drug approval program.

Higher dietary fiber intake — especially from cereals and fruits — may reduce the risk of developing gout among women.

Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.